Abstract
We report on 2 critically ill patients with pneumonitis and acute respiratory distress syndrome due to pandemic (H1N1) 2009 influenza A virus who were treated with intravenous zanamivir and had favorable clinical outcomes. Zanamivir given intravenously may be a therapeutic option in patients with critical illness and mechanical ventilation.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / therapeutic use*
-
Critical Illness
-
Humans
-
Influenza A Virus, H1N1 Subtype / isolation & purification*
-
Influenza, Human / complications*
-
Influenza, Human / drug therapy*
-
Influenza, Human / virology
-
Injections, Intravenous
-
Male
-
Middle Aged
-
Pneumonia / drug therapy*
-
Respiratory Distress Syndrome / drug therapy
-
Treatment Outcome
-
Zanamivir / administration & dosage
-
Zanamivir / therapeutic use*
Substances
-
Antiviral Agents
-
Zanamivir